Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. - Wikidata - awgldk - TriplyDB

Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.

Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.

http://www.wikidata.org/entity/Q40605826

about

Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis Neuroendocrine differentiation in prostate cancer Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure T-type calcium channels blockers as new tools in cancer therapies Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1.TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival Calcium wave signaling in cancer cells Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells.Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells.Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.WT1/EGR1-mediated control of STIM1 expression and function in cancer cells Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function.STIM and Orai proteins as novel targets for cancer therapy. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.Isoform-specific up-regulation of plasma membrane Ca2+ATPase expression during colon and gastric cancer cell differentiation Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis Calcium and cancer: targeting Ca2+ transport.Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways.Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis.Knockdown of TRPM8 suppresses cancer malignancy and enhances epirubicin-induced apoptosis in human osteosarcoma cells.ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?Calcium pumps in health and disease.Endoplasmic-reticulum calcium depletion and disease.Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis.Targeting Ca²⁺ transport in cancer: close reality or long perspective?Cell volume regulation in epithelial physiology and cancer Ion channels and transporters in the development of drug resistance in cancer cells Role of TRP ion channels in cancer and tumorigenesis.ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway.Flavonoids in prevention of diseases with respect to modulation of Ca-pump function.Ca2+ clearance mechanisms in cancer cell lines and stromal cells of the prostate.Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.High expression of TRPM8 predicts poor prognosis in patients with osteosarcoma.The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells.Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells.Modulation of intracellular Ca2+ signalling in HeLa cells by the apoptotic cell death enhancer PK11195.

P2860

Q24302096-9D9A0FCE-F1FF-4AEE-9B8E-41AF8364E540 Q24316639-AF6C1300-6C0B-4EDF-A30A-25879E30DFDE Q24657547-B282BD97-611F-4FE8-92BE-049F61465F48 Q26859201-56764924-0AAE-49B9-974A-70221575BA57 Q28306311-7BAFB18E-F86E-41AE-9851-73B35E87E121 Q30432236-92F26676-6DAB-4A01-9108-F9E9A3EBB22A Q33680223-D47D2945-72AC-4F19-BAA3-C16720FF7ED8 Q34218298-85B5B396-9932-406E-8DBE-93E4F26E1463 Q34283235-1B51243D-3521-4AA8-A917-1FF6AF8A938F Q34438254-1EB59B00-F7A4-4C55-9F07-9B1126BA998B Q34545497-78AF3EA9-FF3D-4C37-ADC8-5E50ED11A4BE Q34997748-9AD3F626-C18D-4C5A-8574-54364E0DE303 Q35575649-7D636CB4-47E0-4389-B319-FCD522E6AD85 Q35785718-B5531F36-E5F5-405F-BF54-7FF3D6077775 Q36122589-67BAB719-5BD7-4F96-AD5D-F8AC747B0BA4 Q36174203-700F06C8-435D-4948-99A2-68D23A514307 Q36218365-BDEE71A8-3E2E-4951-83F7-68A32DF395BB Q36579514-1688BF96-A6C2-4258-AE14-223CA486ABCE Q36856463-AF3CB7AE-63A9-4C18-9F8D-B70036BA4452 Q37074268-D12E00E7-2F04-44A9-8437-5D2FAEB23384 Q37093956-2E87E48E-BFDC-4043-9EB9-40FB95843544 Q37310184-82F55C98-A33A-4DC0-AE9E-354C359D0856 Q37428766-5AF9BEF2-170B-4F46-8A03-191799DD2D07 Q37505601-0365AAA2-85B5-46B7-9F98-257EBFAA23BB Q37566460-2319D4F5-B52C-403A-910C-F4D0AF1172A8 Q37605483-C18E5520-73F9-416A-899C-0F2F28347913 Q37858336-DA7DAE8E-5F0F-48C6-9774-E8D5832294F4 Q37937313-D50ABFB3-C4BB-478C-893B-6132E58E8899 Q38072110-E3F758C4-FEEE-4C64-9F15-7F92C32DB974 Q38134726-163E4EBC-9D47-4EE6-91A3-9089F7B23386 Q38184991-9EBAD15C-B94A-44B2-8F5E-F54F3252E094 Q38722167-84038F01-520D-4A7C-9BEE-4D0F6929A804 Q38727575-B3A19F7C-B02E-48D1-BD0C-2DB86C445959 Q38861794-C40FC4E3-7437-4FCF-86CE-4A637139500A Q39095833-73BBF55A-C794-42DE-A28A-1B403E2E68D5 Q39375869-F4AB8220-2407-481D-9DC1-D2207C381354 Q39572149-91483989-12EF-4F08-B4CC-1D4B61CD199C Q39656692-7F6FC49E-E337-4787-89C8-D02F1C800A91 Q39737891-8F421141-AAC0-4D5B-B5A0-60AF97633939 Q39782298-A6A2D6B9-ECE2-4077-9A1A-7DECF32C6E04

P2860

Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.

http://www.wikidata.org/entity/Q40605826

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Ca2+ homeostasis and apoptotic ...... ntiated prostate cancer cells.

@en

type

label

Ca2+ homeostasis and apoptotic ...... ntiated prostate cancer cells.

@en

prefLabel

Ca2+ homeostasis and apoptotic ...... ntiated prostate cancer cells.

@en

P1433

Q40605826-835DBBC6-1CD9-46FD-BCEA-B23BB599727E

P1476

Q40605826-E067A5BF-CFB9-4CB0-BFF4-79475F14B955

P2093

Q40605826-016186E1-3ED7-4C79-B52D-7CF70540FB7A

Q40605826-0C1634BA-BBB0-458F-AC1C-621A8C54D2AA

Q40605826-2912CD84-547D-45C7-AA0D-326228C9B68D

Q40605826-61F3B10D-EC4D-471D-8EBF-97D327135A34

Q40605826-782A78DA-3AA7-4159-8358-96925428C56A

Q40605826-A9057EBB-B2D8-48B8-B848-003B6DB90ED0

Q40605826-AB5E34D0-CFFA-4CA1-BF0E-1448C5179144

Q40605826-D2525D1E-EC7B-4BB8-9D1F-24493B9CDE92

Q40605826-D72A19AF-6E22-4FF3-B2CE-D6CB6E6A868B

Q40605826-E1578F6C-D028-4BAA-82AE-2FAB1A807B5D

P2860

Q40605826-06F86A7C-F524-4B00-83BA-C653B18C9091

Q40605826-094F8EAE-8376-4829-BF09-5D2EAB362527

Q40605826-16603145-0559-40B4-92AB-9FACECEA8563

Q40605826-2632D2DC-0C2D-4C68-A2AE-C4DA5F3A6585

Q40605826-33F81405-1B25-4DE1-803E-AA64A944608D

Q40605826-3427E3DB-70EF-44D4-8B66-A34C625A8C56

Q40605826-41133C8B-291A-4EA1-B644-77425170AC7B

Q40605826-452AA6DD-683A-4563-BD28-27D08582011D

Q40605826-4C54CDBE-99D6-4D0A-8A58-4137F0822066

Q40605826-52F01C1D-1F07-4B75-8C7B-912DDB797E15

P2888

Q40605826-A6B7A0A4-49AC-43A5-BDA9-1FD465294397

P304

Q40605826-3043E7F0-3378-4301-A4E4-91F8CE23282E

P31

Q40605826-1D8BCD2B-766A-414E-8F4F-7BE14DED5B35

P356

Q40605826-93FE48E4-1327-4327-A5D3-4C78EE336A42

P433

Q40605826-35E755D6-1690-4FC1-9A63-AB48E6D9E456

P478

Q40605826-8B0C7666-4306-4A68-B2FC-A1E522D6178A

P577

Q40605826-8160EB72-E9BD-4D36-9E58-6EB4769B39F7

P5875

Q40605826-E50D2838-47B0-4398-AD51-BA2C3A4BAD46

P6179

Q40605826-441E7108-F2FF-406B-A4B2-DDB60AF44AE1

P698

Q40605826-5E382F64-CB35-40A4-86B0-99CB827F3120

P921

Q40605826-F1E01980-2B88-4E8D-8FFA-E82C734AE1F1

P356

P1433

Cell Death & Differentiation

P1476

Ca2+ homeostasis and apoptotic ...... ntiated prostate cancer cells.

@en

P2093

Bonnal JL

http://www.w3.org/2001/XMLSchema#string

Lepage G

http://www.w3.org/2001/XMLSchema#string

Mariot P

http://www.w3.org/2001/XMLSchema#string

Mauroy B

http://www.w3.org/2001/XMLSchema#string

Prevarskaya N

http://www.w3.org/2001/XMLSchema#string

Roudbaraki M

http://www.w3.org/2001/XMLSchema#string

Shuba Y

http://www.w3.org/2001/XMLSchema#string

Skryma R

http://www.w3.org/2001/XMLSchema#string

Vanden Abeele F

http://www.w3.org/2001/XMLSchema#string

Vanoverberghe K

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

The role of calcium in the regulation of apoptosis

Death receptors: signaling and modulation

The development of androgen-independent prostate cancer

Calcium signaling and cytotoxicity.

Neuroendocrine cells in tumour growth of the prostate.

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status.

Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.

The TRP ion channel family.

P2888

P304

321-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CDD.4401375

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8951618

http://www.w3.org/2001/XMLSchema#string

P6179

1003134692

http://www.w3.org/2001/XMLSchema#string

P698

14685164

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process